top of page
Wide banner medical illustration. Subtle cross‑section pattern of bladder tissue cells in

Who we are

CartosomeTx is built around Cartosome™, our targeted delivery platform. Cartosome™ is a fusogenic LNP–exosome system designed to get the right payloads inside the right cells in the bladder, starting with STAT3‑driven non‑muscle invasive bladder cancer.

​

Rather than developing a single drug, we are building a delivery backbone that can be adapted to different payloads and, over time, to other hard‑to‑reach solid tumours. Bladder‑first gives us a focused place to prove that Cartosome™ can safely and effectively deliver intracellular therapies where they are needed most.

​

Our team combines experience in advanced therapies, GMP manufacturing, and clinical development. That shapes how we design Cartosome™ to work not only in theory, but in real‑world manufacturing and clinical settings.

Cartosome™ platform

Cartosome™ is our targeted delivery platform.

​Combining fusogenic lipid nanoparticles and exosome biology to deliver therapeutic payloads

3D medical illustration of a single lipid nanoparticle with a glowing inner core merging w

Cartosome™ fusogenic core

Cartosome™ starts with a fusogenic lipid core designed to merge with cell membranes. This helps our particles deliver payloads directly inside cells, rather than just bathing the surface 

3D medical illustration of several semi‑

Exosome‑inspired outer layer

Around the core, Cartosome™ uses exosome‑inspired components that help the system interact with cells in the tissue environment. This layer is designed to support targeting, uptake, and stability in local  delivery.

cec53492-a03a-4aea-83af-4a630c125046.png

Payload‑ready backbone

Cartosome™ is built as a payload‑ready backbone. It is designed to carry different therapeutic cargos aimed at STAT3‑driven disease in the bladder first, with the flexibility to adapt to other targets and solid tumours as the platform matures.

Contact & Partnerships

We are currently focused on advancing Cartosome™ for non‑muscle invasive bladder cancer and exploring collaborations around delivery science, biology, and clinical development.

​

For investors, researchers, or potential partners interested in Cartosome™, please reach out using the form below

2nd Floor

College House17 King Edwards RoadRUISLIP,  London,

HA4 7AE UNITED KINGDOM

  • LinkedIn

Thanks for submitting!

2nd Floor College House
17 King Edwards Road
RUISLIP, London, HA4 7AE
UNITED KINGDOM

© 2023 by CartosomeTx. All rights reserved.

  • LinkedIn
bottom of page